EAE model in rodents or other species IMO not relevant IMHO
That's a little harsh given the EAE model was what prompted the drug being tried in humans in the first place (if I recall correctly). But maybe you are correct in the current context.
Some sort of biomarker for PK/PD would I think go quite a way to reassure the FDA here.